Skip to main content

Unlocking New Frontiers in Cancer Screening

Multiomics Blood Test for cancer screening is detecting early signs for proactive and personalized care.

Enroll Now

Better to be Safe

Each year, approximately 150,000 new cases of colorectal cancer are diagnosed in the United States alone, and a significant portion of these cases can be prevented through regular colorectal Cancer Screening. Early detection is crucial in the fight against cancer, as it increases treatment options and improves outcomes.

Multiomics Blood Tests offer a comprehensive approach to cancer screening, analyzing multiple biomarkers in the blood to detect potential signs of cancer at an early stage. This advanced technology enables us to identify unique molecular signatures associated with different cancer types, including lung cancer, breast cancer, and colorectal cancer, among others.

Hightower’s dedication to research and excellence ensures that our Multiomics Blood Tests clinical trials uphold the highest standards of accuracy and reliability. Hightower aims to redefine colorectal cancer screening and improve outcomes through innovative Multiomics Blood Tests.

*Participation in the Clinical Trial is completely free of cost and is your choice.

*To participate, fill out the form, and someone from our research staff will call you to determine your eligibility for the Clinical Research Study.

Hope Through Multiomics Blood Test for Cancer Screening

Multiomics blood tests for cancer screening represent a cutting-edge approach in early detection and prevention. By analyzing various biological markers in the blood, such as DNA, RNA, proteins, and metabolites, these tests offer a comprehensive assessment of an individual’s cancer risk.

Hightower clinical leads the way in leveraging advanced multiomics methodologies to pioneer blood-based screening for multiple cancers. By detecting cancers at their earliest stages, we aim to revolutionize cancer screening and treatment, ultimately improving patient outcomes and reducing mortality rates associated with the disease.

We strive to make cancer screening accessible and effective. With our commitment to innovation, Hightower aims to reshape the landscape of cancer screening, bringing in a new era of proactive and effective screening strategies.

*All study procedures and study-related treatment, including the investigational drug, are free of cost, and insurance is not required to participate.

*The study doctor will take you through every step of the Clinical Trial before you decide to participate and will answer any questions you have about the study treatment.

What to Expect

If you decide to participate in the Clinical Trials, by filling out the form above, someone from the study team will contact you to determine your eligibility. The team will go over the study details with you to see if you meet the eligibility criteria for the Cancer Screening Clinical Trials.

You will be invited to the study location for screening if you meet the criteria. The study site will be within a 50-mile radius of your current location. The study doctors will advise you on the duration of the clinical trials for cancer and the implications of your involvement in this research study. We invite you to ask as many questions as you like. After thoroughly explaining everything to the participants, they will be requested to sign an Informed Consent Form. We value transparency between our participants and investigators

*Study-related care is offered at no charge. Expert physicians and healthcare professionals conduct thorough physical exams and assessments.*


30 Years and Older


Male & Female



Current Status


Colorectal Cancer Blood Screening: Detecting the Silent Invader

The Multiomics Blood Test for Cancer Screening uncovers hidden threats within the body, offering a comprehensive analysis that goes beyond traditional screening methods.

As a cutting-edge technology, this test examines multiple biomarkers in the blood, providing insights into various cancer types at an early stage. It serves as a vital tool in the fight against cancer, empowering individuals with proactive and personalized healthcare solutions.

Colorectal cancer often lurks undetected, making regular blood screening a crucial step in early detection and prevention.

Hightower’s Blood Test for Colorectal Cancer offers a non-invasive approach to identifying potential risks, allowing for timely interventions and improved outcomes. By staying vigilant and incorporating regular screenings into your healthcare routine, you can take proactive steps toward protecting your health and well-being.

Frequently Asked Questions

What is a Multiomics Blood Test for Cancer Screening?

The Multiomics Blood Test analyzes multiple biomarkers in the blood to detect early signs of various cancer types, enabling proactive healthcare.

How accurate is the Multiomics Blood Test?

Hightower’s Multiomics Blood Test maintains high accuracy levels, ensuring reliable results crucial for early detection and personalized treatment planning.

Who should consider Multiomics Cancer Screening?

Individuals with a family history of cancer, aged 40 and above, or those seeking proactive cancer prevention strategies can benefit from Multiomics Cancer Screening.